May 2026
287 articles-
-
May 27 · 09:00Market Watch
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
-
May 27 · 00:27Bio Business News
Big Pharma Discovers Gold Mine in Royalty Stream Opportunities
-
May 26 · 22:40Market Watch
Market Signals Hidden in Orphan Drug Status Designations That Biotech Investors Can't Ignore
-
May 26 · 20:51Bio Business News
Breaking Down Patent Cliff Risk and the Hidden Opportunities for Biotech Investors
-
May 26 · 19:06World News
Breaking Down the Revolutionary Impact of Global Regulatory Filing on Modern Healthcare
-
May 26 · 17:41Biotechnology Daily
Breakthrough IND Filing Milestone Transforms Biotech Investment Landscape
-
May 26 · 16:14Market Watch
Market Signals Every Biotech Investor Should Watch as Gene Therapy Advances Reshape Healthcare
-
May 26 · 14:48Biotechnology Daily
Digital Transformation Accelerates NDA Submission Processes Across Pharmaceutical Giants
-
May 26 · 13:16Market Watch
Breaking Down Orphan Drug Status Impact on Biotech Valuations and Market Dynamics
-
May 26 · 11:52Market Watch
Market Signals Every Biotech Investor Should Watch for the Next Short Squeeze
-
May 26 · 11:36Market Watch
Breakthrough Gene Therapy Advance Triggers Massive Market Realignment as Big Pharma Scrambles for Position
-
May 25 · 23:46Market Watch
Record Biotech Short Interest Creates Perfect Storm for Market Volatility
-
May 25 · 22:07Biotechnology Daily
Emerging Trends Show PDUFA Date Pressure Reshaping Drug Development Strategies
-
May 25 · 21:57World News
Market Authorization Granted Signals Transform Global Biotech Investment Landscape
-
May 25 · 19:06Biotechnology Daily
Breaking Down the IND Filing Milestone That Could Transform Your Biotech Portfolio Returns
-
May 25 · 17:42Bio Business News
Big Pharma's Growing Fascination with Royalty Stream Opportunities Reshapes Investment Strategy
-
May 25 · 16:14Biotechnology Daily
Breaking Down the FDA Approval Catalyst That's Reshaping Biotech Investment Strategy
-
May 25 · 15:16Market Watch
Breaking Down Orphan Drug Status Market Signals That Drive Biotech Investment Decisions
-
May 25 · 13:16Market Watch
Orphan Drug Status Unlocks Billion-Dollar Market Opportunities for Pharmaceutical Companies
-
May 25 · 11:47Market Watch
Market Signals That Define the New Era of Biosimilar Competition
-
May 25 · 11:07Market Watch
Emerging Biotech Short Squeeze Dynamics Are Reshaping Investment Landscapes
-
May 24 · 22:44Market Watch
Record Patent Cliffs Drive Unprecedented Wave of Biosimilar Competition Across Global Markets
-
May 24 · 21:13Biotechnology Daily
Record Investment Flows Transform Oncology Pipeline Catalyst Companies Into Global Growth Engines